Lorke DE - Search Results

1

Reversible cholinesterase inhibitors as pre-treatment for exposure to organophosphates: assessment using azinphos-methyl.

Petroianu GA, Nurulain SM, Hasan MY, Kuča K, Lorke DE. Petroianu GA, et al. Among authors: lorke de. J Appl Toxicol. 2015 May;35(5):493-9. doi: 10.1002/jat.3052. Epub 2014 Sep 3. J Appl Toxicol. 2015. PMID: 25186309

2

Paraoxon has only a minimal effect on pralidoxime brain concentration in rats.

Petroianu GA, Lorke DE, Hasan MY, Adem A, Sheen R, Nurulain SM, Kalasz H. Petroianu GA, et al. Among authors: lorke de. J Appl Toxicol. 2007 Jul-Aug;27(4):350-7. doi: 10.1002/jat.1213. J Appl Toxicol. 2007. PMID: 17265425

3

Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime.

Lorke DE, Hasan MY, Nurulain SM, Sheen R, Kuca K, Petroianu GA. Lorke DE, et al. J Appl Toxicol. 2007 Sep-Oct;27(5):482-90. doi: 10.1002/jat.1229. J Appl Toxicol. 2007. PMID: 17309042

4

In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.

Lorke DE, Hasan MY, Arafat K, Kuca K, Musilek K, Schmitt A, Petroianu GA. Lorke DE, et al. J Appl Toxicol. 2008 May;28(4):422-9. doi: 10.1002/jat.1344. J Appl Toxicol. 2008. PMID: 18344198

5

Entry of oximes into the brain: a review.

Lorke DE, Kalasz H, Petroianu GA, Tekes K. Lorke DE, et al. Curr Med Chem. 2008;15(8):743-53. doi: 10.2174/092986708783955563. Curr Med Chem. 2008. PMID: 18393843 Review.

6

Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon.

Lorke DE, Hasan MY, Nurulain SM, Shafiullah M, Nagelkerke N, Petroianu GA. Lorke DE, et al. Neurotoxicology. 2008 Jul;29(4):663-70. doi: 10.1016/j.neuro.2008.03.006. Epub 2008 Mar 22. Neurotoxicology. 2008. PMID: 18457881

7

Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity.

Lorke DE, Nurulain SM, Hasan MY, Kuca K, Musilek K, Petroianu GA. Lorke DE, et al. J Appl Toxicol. 2008 Oct;28(7):920-8. doi: 10.1002/jat.1359. J Appl Toxicol. 2008. PMID: 18548743

8

Pyridinium oxime reactivators of cholinesterase inhibited by diisopropyl-fluorophosphate (DFP): predictive value of in-vitro testing for in-vivo efficacy.

Petroianu GA, Lorke DE. Petroianu GA, et al. Among authors: lorke de. Mini Rev Med Chem. 2008 Nov;8(13):1328-42. doi: 10.2174/138955708786369555. Mini Rev Med Chem. 2008. PMID: 18991751 Review.

9

The organophosphate paraoxon has no demonstrable effect on the murine immune system following subchronic low dose exposure.

Fernandez-Cabezudo MJ, Azimullah S, Nurulain SM, Mechkarska M, Lorke DE, Hasan MY, Petroianu GA, Al-Ramadi BK. Fernandez-Cabezudo MJ, et al. Among authors: lorke de. Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):891-901. doi: 10.1177/039463200802100413. Int J Immunopathol Pharmacol. 2008. PMID: 19144274 Free article.

10

Analysis of pralidoxime in serum, brain and CSF of rats.

Kalász H, Szöko E, Tábi T, Petroianu GA, Lorke DE, Omar A, Alafifi S, Jasem A, Tekes K. Kalász H, et al. Among authors: lorke de. Med Chem. 2009 May;5(3):237-41. doi: 10.2174/157340609788185882. Med Chem. 2009. PMID: 19442213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page